Texas Update in Cardiovascular Advancements

Saturday | February 9, 2019
19th TEXAS UPDATE IN CARDIOVASCULAR ADVANCEMENTS 2020

Overview & Enduring Resources

Course Director: James T. Willerson, MD

Over the past decade, physicians and scientists have worked diligently to find ways to combat the various physiological and behavioral risk factors and the genetic alterations associated with cardiovascular disease. This one-day symposium features lectures and discussions by distinguished faculty who provide current information on the status and future directions of cardiovascular medicine and surgery.

 

Program Overview

Heart and vascular disease are the #1 killers throughout the world for men, women and children. A death from heart or vascular disease occurs every 33 seconds, with 2,600 deaths occurring each day, and more than one million deaths occurring each year. There are 40 million women in the United States presently living with heart or vascular disease. In contrast, there are 8 million women living with cancer in the US presently. A woman is 5 times more likely to die of heart attack than of breast cancer. More women die of heart and vascular disease then of all cancers combined. A young person dies on the playing fields in the US every 2 to 3 weeks. These deaths are almost always caused by underlying but previously unsuspected heart and vascular disease.

Over the past decade, physicians and scientists have worked diligently to find ways to combat the various physiological and behavioral risk factors and the genetic alterations associated with cardiovascular disease. Our one-day symposium will feature lectures and discussions by distinguished faculty who will provide current information on the status and future directions of cardiovascular medicine and surgery. The faculty will highlight recent progress in the diagnosis and treatment of cardiovascular disease, as well as new therapeutic modalities.

Target Audiance

The audience for this continuing medical education activity includes cardiologists, cardiovascular surgeons, internists, clinical researchers, nurses, technicians, and all interested in cardiovascular disease.

Agenda

18th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium

All presentations are followed by Q&A with the speaker

7:30 am    Continental Breakfast and Exhibits

8:00         Welcome and Introductions |  James T. Willerson, MD

8:15          PCKS9 Inhibitors: Are They Alternatives to Treating Elevated LDLs in Patients Intolerant of Statins? | Vijay Nambi, MD, PhD

8:45         Non-Invasive Imaging of Vascular Inflammation | Darren Woodside, PhD

9:15          Latest Development in Treating Patients with TAVR | David Fish, MD

9:45         Hormonal Therapy for Post Menopaused Women at High Risk of CAD: What is Best? | Stephanie Coulter, MD

10:15        Closure Devices for Mitral Valve Regurgitation, ASDs, and VSDs:What Progress Has Been Made? | Guilherme Silva, MD

11:00        Advances in Radiofrequency Ablation of Atrial Fibrillation |Abdi Rasekh, MD

11:30        Questions of the Speakers


Presentation of Ray C. Fish Award and Luncheon | Texas Heart Institute The Ansary Atrium

Noon     Introduction of the Ray C. Fish Award and Recipient |  James T. Willerson, MD

12:05       Presentation of the Ray C. Fish Award | James T. Willerson, MD

12:15        Luncheon in honor of Ray C. Fish Award Recipient | Emerson Perin, MD, PhD


18th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium

1:15          Ray C. Fish Lecture:  Cell Therapy for the Heart: A Journey to Approval Emerson Perin, MD, PhD Medical Director, Texas Heart Institute  (Houston, Texas)

2:00        Treating Patients with CHF and LV Systolic Dysfunction by Treating Mitral Regurgitation | Andrew B. Civitello, MD

2:30        Update on Treatment of DVT | Zvonimir Krajcer, MD

3:00        Treating CHF by Stimulating Cardiogenesis Directly | James F. Martin, MD, PhD

3:30        Questions of the Speakers

3:45        Final Comments and Adjourn |  James T. Willerson, MD

 

Downloadable Agenda

Objectives & Credit Designation

Educational Objectives

At the conclusion of this symposium, participants should be able to –

  • Discuss recent scientific advances in lipid management and the use of statins for acute and chronic coronary artery disease.
  • Recognize the potential therapeutic options with stem cell therapy for cardiovascular disease, including congestive heart failure.
  • Discuss the use of stem cell therapy in the regeneration of damaged heart tissue.
  • Highlight new advances in electrophysiology, including biventricular pacing, defibrillation, and ablation for arrhythmias.
  • Discuss heart disease in women
  • Discuss TAVR to treat valvular aortic stenosis

Credits Offered

6.75 AMA PRA Category 1 Credits™

Lodging

There are several hotels in the Texas Medical Center:

Marriott Medical Center
6580 Fannin Street
Phone: 713-796-0080

Hilton Houston Plaza
6633 Travis Street
Phone: 713-313-4000

InterContinental Houston – Medical Center
6750 Main St, Houston, TX 77030
Phone: 713- 422-2779